ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

July 17-21, 2021. Philadelphia, PA.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z
  • Abstract Number: PB0848

    Validating Lactate Dehydrogenase (LDH) as a Component of the PLASMIC Predictive Tool (PLASMIC-LDH)

    C.C.K. Liam1,2,3, J.Y.-H. Tiao1,2, Y.Y. Yap3, J. Sathar3, Y.L. Lee4, S. McRae5, A. Davis6, J. Curnow7, R. Bird8, P. Choi9, P. Angchaisuksiri10, S.L. Tien11, J.C.M. Lam12, D. Oh13, J.S. Kim14, S.-S. Yoon15, R. Wong16, S. Macpherson17,18, E. Merriman19,20, R.I. Baker1,2

  • Abstract Number: PB0798

    Validation of a de novo Paediatric Warfarin Nomogram

    S. Jones1,2,3, P. Monagle1,4,3, A. Allan2, S. Chen2, K. Dawson2, A. Kuzmitsky2, M. Pham-Crepps2, E. Renner-Hahn2, A. Greenway1, F. Newall1,2,3

  • Abstract Number: PB0100

    Validation of a New Kit for the Quantitative Determination of Chromogenic Factor IX Activity

    T. Quinton1, R. Clarke1, J. Fraser1, K.M Black1, A. Sadeghi-Khomami1

  • Abstract Number: PB0382

    Validation of Mixing Test Formula for the Discrimination between Lupus Anticoagulant and Acquired Hemophilia A in New APTT Reagent

    O. Kumano1, D. Shimomura2, K. Kitano1, N. Arai1, T. Matsumoto3.

  • Abstract Number: PB0126

    Validation of the Bioequivalence of USP Potency Adjusted Porcine, Ovine and Bovine Heparins

    N. Baig1, M. Jaradeh1, A. Kouta1, W. Jeske1, D. Hoppensteadt1, J. Walenga1, O. Iqbal1, F. Siddiqui1, M. Bakhos1, J. Fareed1

  • Abstract Number: LPB0137

    Validation of the HULL Clinical Prognostic Rule (CPR) for Incidental Pulmonary Embolism in Ambulatory Cancer Patients

    F. Haque1,2, G. Bozas1, C. Huang2, A. Pillai1, S. Mirza1, J. Ryde1, S. Sethi1, M. Kolodziej1, A. Stephens1, S. Raper1, E. Gollins1, G. Avery1,2, A. Maraveyas1,2

  • Abstract Number: PB0257

    Value of Laboratory Parameters in the Clinical Monitoring of Patients with SARS-COV-2 Infection (COVID-19)

    M. Moreno Carbonell1, A. Gómez Martínez1, C. Hernández Mata1, E. González Gómez1, S. Martín-Consuegra Ramos1, M. Civeira Marín1, A. López Peña1, C. Rodríguez Lefler1, A.J. García Ortego1, S.F. Pinzón Mariño2, N. Fernández Mosteirin1, J.M. Calvo Villas1

  • Abstract Number: PB0854

    Variable Serotonin Release Assay Pattern and Characteristics of PF4-specific Antibodies in Heparin-Induced Thrombocytopenia, and Clinical Impact

    N. Charuel1,2, J. Rollin1,3, Y. Gruel1,3, E.-A. Guéry3, M.-A. May4,5, C. Pouplard1,3, C. Vayne1,3

  • Abstract Number: PB0114

    Various Receptors Are Related with the APC-induced Suppression of Osteoclast Differentiation

    N. Akita1, K. Yoshida2, T. Okamoto3, K. Asanuma4, K. Suzuki1, T. Hayashi5

  • Abstract Number: PB0931

    Vascular Abnormalities in Patients with Von Willebrand Disease: A Scoping Review

    N. Chornenki1, M. Shanjer2, P. James1

  • Abstract Number: OC 68.4

    Vascular Endothelial Damage in the Pathogenesis of Preeclampsia and SARS-CoV-2 Infection in Pregnancy

    M. Palomo1, S. Torramadé-Moix2, A.B. Moreno-Castaño2, J. Martinez-Sanchez3, L. Bonastre2, M. Pino2, P. Sanchez4, L. Youssef5, F. Crovetto5, G. Escolar2, E. Carreras6, P. Castro7, E. Gratacós5, F. Crispi5, M. Diaz-Ricart2

  • Abstract Number: PB0261

    Venous Thromboembolic Disease in Patients Wwith SARS-CoV2 Infection: In Search of a Predictive Biomarker

    P. Silva de Tena1, R. Gómez de Antonio1, R.M. Martín Rojas1, G. Perez Rus1,2,3, J.L. Díez-Martín1,2,3, C. Pascual Izquierdo1,2,3

  • Abstract Number: PO182

    Venous Thromboembolism as the First Presentation of Multiple Myeloma

    X. Ye1

  • Abstract Number: PO194

    Venous Thromboembolism in a 30 Year Old Female: Synergic Effect of Oral Contraceptive and Elevated Factor VIII?

    F. Laouan Brem1, F. Mouedder1, C. Toutai1, N. Ismaili1,2, N. El Ouafi1,2

  • Abstract Number: PB0225

    Venous Thromboembolism in Cancer Patients with SARS-CoV-2 Infection

    D. Attia1, W. Wei2, M. Wilks1, B. Tripp1, C. D’Andrea1, D.E. Angelini1, A.A. Khorana1

  • Abstract Number: PB1117

    Venous Thromboembolism in Children with Acute Lymphoblastic Leukemia in China: A Multi-center Clinical Study

    M. Yin1, H. Wang2, J. Yu3, J. Gao4, M. Yang5, N. Wang6, T. Liu7, S. Shen8, A.W. Leung9, F. Zhou10, X. Wu11, J. Huang12, H. Li13, S. Hu14, X. Tian15, H. Jiang16, X. Zhai2, J. Tang8, Q. Hu1

  • Abstract Number: OC 25.2

    Venous Thromboembolism in Critically-ill Patients with Pneumonia in the Pre-COVID-19 Era: Data from a Large Public Database

    M.P.L. Ferreira1, S. Barco2, J.M Annichino-Bizzacchi3,1, E.V De Paula3,1, F.A. Orsi1

  • Abstract Number: PB0171

    Venous Thromboembolism in Hospitalized Critical and Non-critical COVID-19 Patients: A Systematic Review and Meta-analysis

    E. Mansory1,2, S. Srigunapalan1, A. Lazolangner1

  • Abstract Number: PB1192

    Venous Thromboembolism in Patients Hospitalized with COVID-19: Results from the Brazilian COVID-19 Registry

    W.C. Silveira1, S.M. Rezende1, M.A.P. Martins1, M.C. Pires1, R.T. Silva1, L.E.F. Ramos1, M.V.R.S. Silva1, T.L.S. Sales2, C.C.R. Cimini3, M.H. Guimarães Júnior4, F.G. Aranha5, M.C.A. Nogueira6, L.B. Moreira7, T.O. Fereguetti8, P.L. Assaf9, M. Carneiro10, M.S. Marcolino1, S.F. Araújo11, A.V. Schwarbold12, G.A.N. Bastos13

  • Abstract Number: PB1215

    Venous Thromboembolism Profile and Management Differences between Ages in a RIETE’s Hospital of Brazil

    R. Santos de Oliveira Júnior1, J. Abreu Couto Vieira1, A.T. Cavalcanti Rocha1

  • Abstract Number: PO173

    Venous Thromboembolism Prophylaxis during Hospitalization: Evidence-based Recommendation (by an Internal Medicine Team)

    F.J. Vázquez1, M.F. Grande Ratti1, M.G. Vallone1, P.G. Paula Guadalupe Gutierrez1, M.B. Bonella1, D. Andresik1, A. Freixas1, M.L. Peroni1, D.S. Thomas1, C.M.U. Ungaro1, M. Burgos1, D.H. Giunta1, H.M. Recchioni1, M.M. Serra1, B. Martinez1, H. Michelangelo1, J.A. Pollán1, B.R. Boietti1, V.A. Peuchot1

  • Abstract Number: PB1228

    Venous Thromboembolism Prophylaxis in Patients with Severe Burns in a Large Trauma Hospital

    R. Brazilek1, H. Cleland1

  • Abstract Number: PB1225

    Venous Thromboembolism Risk Profiles and Prophylaxis in Medical Oncology Inpatients: a Subgroup Analysis of the Observational DissolVE-2 Study

    R. Xu1, Y. Shi2, Y. Gao3, Z. Zhai4, W. Li5, X. Qin6, J. Qu7, C. Wang4

  • Abstract Number: PB1120

    Venous Thromboembolisms are Significantly Associated with Central Venous Catheter Loss in Pediatric Cancer Patients

    Z. Forbrigger1, P. Moorehead2, K. Kulkarni3

  • Abstract Number: PB0092

    Viscoelastic Haemostatic Assay Comparison for Perioperative Coagulation Assessment

    J. Fanning1,2,3, S. Roberts4,1, C. Anstey5, K. Poon3,6, A. Incani3,1, J. Fraser2,1,3

  • Abstract Number: PB0877

    Vitamin B-12 Deficiency and Pseudo Thrombotic Microangiopathy: A Case Series

    C. Jones1, R. Kumar2

  • Abstract Number: PB1143

    VKORC1 -1639AA Genotype Is a Possible Protective Factor for Venous Thromboembolism Development in Patients with FII G20210A Mutation from North-Western Russia

    S. Kapustin1, A. Chechulova2, S. Svitina1, J. Sidorova1, V. Burakov1, V. Soroka2, V. Soldatenkov1, L. Papayan1

  • Abstract Number: OC 46.4

    VMX-C001 Is an Effective FXa-DOAC Reversal Agent and Displays No Thrombogenic Potential in Comparison to Andexanet Alfa and 4PCC

    D. Verhoef1,2, T. Gomes1, G. Short1, P.H. Reitsma1,2

  • Abstract Number: PB0930

    Von Willebrand Factor (VWF) Collagen IV Binding Defect – A Potentially Overlooked Cause for Excessive Bleeding Phenotype

    M. Escobar1, N. Montanez1, J. Lemons1, K. Friedman2

  • Abstract Number: PB0915

    von Willebrand Factor (VWF) Multiplex Activity Assay Differentiation of Low VWF/Type 1 von Willebrand Disease (VWD) and Variant VWD: Analysis from the Comparative Effectiveness in the Diagnosis of VWD

    J.C. Roberts1, P.A. Christopherson2, M.D. Tarantino1, S.E. Gonzales1, P.A. Morateck2, C.L. Perry2, V.H. Flood2, T.C. Abshire2, R.R. Montgomery2, Z.P. Investigators2

  • Abstract Number: PB0166

    Von Willebrand Factor and ADAMTS13 Activity as Endothelial Injury Markers and their Prognostic Value in COVID-19

    A. Marco1,2, P. Marco1,2,3

  • Abstract Number: OC 66.3

    Von Willebrand Factor Contributes to Alternative Complement Pathway Activation, Microangiopathy, and Renal Dysfunction in Murine Thromboinflammation

    P. Jacobi1,2, S. Sartain1,2

  • Abstract Number: PO158

    Von Willebrand Factor Multimer Distribution Analysis in a Group of Patients Diagnosed with von Willebrand Disease

    E. Wojtasinska1, O. Krupinska1, M. Malachowska1, A. Szczepaniak1, J. Rupa-Matysek1, L. Gil1

  • Abstract Number: PB0743

    Von Willebrand Factor Propeptide to Antigen Ratio: Evidence of Endothelial Activation in HIV Infected Pregnancy

    E. Schapkaitz1, E. Libhaber1, B. Jacobson1, M. Meiring2, H. Büller3

  • Abstract Number: PB0792

    VTE Incidence in Children with Different Blood Disorders: Data from a Large Monocenter Retrospective Cohort Study

    P.A Zharkov1, D.A Evstratov1, K.A Voronin1, D.V Fedorova1, A.V Pshonkin1

  • Abstract Number: PB1220

    VTE Prophylaxis in Foot and Ankle Surgery: A Worldwide Survey

    R. Zambelli1,2, S. Frolke3, B. Nemeth4, D. Baumfeld2, C. Nery5, C. Ortiz6, S. Cannegieter4, S. Rezende2

  • Abstract Number: PB1234

    VTE Risk at Discharge

    K. Patel1, R. Fulton1, J. Knapp1, T. Knox1, H. Lombardo1, M. Lóser1, A. Hallam2, A. Macchiavelli1,2

  • Abstract Number: PB1257

    VTE Treatment Planning: A Mixed-method Analysis of Clinical Challenges, Knowledge, and Confidence Gaps in Selecting Evidence-based Treatment

    A. Spyropoulos1, P. Lazure2, S. Kaatz3, A. Khorana4, S. Zahabi2, K. McCrae4, C. Pollack5, S. Péloquin2

  • Abstract Number: OC 11.1

    VWF-bound GPIbα under Flow Activates Human Platelet TF and Surface-bound FVII, Sparking Clotting Reactions, Thrombin Generation and Fibrin Deposition

    O. Panes1, M.F. Becerra1, R. Valle2, C.G. Sáez1, P. Hidalgo1, J. Pereira1, J. Royce3, D. Pedrosa4, W. Ruf4,5, D. Mezzano1

Jump to:  View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley